16:03 EDT Evaxion Biotech (EVAX) files $50M ordinary shares offering
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EVAX:
- Evaxion Biotech to Present at Key Conferences in 2025
- Evaxion Biotech Extends Phase 2 Trial for Cancer Vaccine EVX-01
- Evaxion Biotech extends Phase 2 trial with EVX-01 to enhance clinical data
- Evaxion Biotech Secures Nasdaq Compliance, Strengthens Financial Position
- Evaxion Biotech re-established compliance with Nasdaq
Questions or Comments about the article? Write to editor@tipranks.com